These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24134502)

  • 1. Commentary: rabeprazole improves symptoms in patients with functional dyspepsia in Japan - author's reply.
    Iwakiri R
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1322-3. PubMed ID: 24134502
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.
    Yap PR; Mahadeva S; Goh KL
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1321-2. PubMed ID: 24134501
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.
    Iwakiri R; Tominaga K; Furuta K; Inamori M; Furuta T; Masuyama H; Kanke K; Nagahara A; Haruma K; Kinoshita Y; Higuchi K; Takahashi S; Kusano M; Iwakiri K; Kato M; Hongo M; Hiraishi H; Watanabe S; Miwa H; Naito Y; Fujimoto K; Arakawa T
    Aliment Pharmacol Ther; 2013 Oct; 38(7):729-40. PubMed ID: 23957383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there any effect of sequential eradication therapy of helicobacter pylori on functional dyspepsia symptom resolution?
    Sarikaya M; Filik L; Doğan Z; Ergül B
    Acta Gastroenterol Belg; 2013 Dec; 76(4):448-9. PubMed ID: 24592555
    [No Abstract]   [Full Text] [Related]  

  • 6. New dual therapy for primary treatment of Helicobacter pylori infection: A prospective randomized study in Shanghai, China.
    Ren L; Lu H; Li HY; Zhu LY; Xu XQ; Gu LY; Ge ZZ; Li XB
    J Dig Dis; 2014 Nov; 15(11):622-7. PubMed ID: 25205201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Update on current care guidelines. A current care guideline: recurrent upper gastrointestinal symptoms].
    Paikka N
    Duodecim; 2012; 128(22):2376-7. PubMed ID: 23342484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women and functional dyspepsia.
    Napthali K; Koloski N; Walker MM; Talley NJ
    Womens Health (Lond); 2016; 12(2):241-50. PubMed ID: 26901578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
    Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Sakamoto H; Kuramoto T; Kojima K; Sanomura M; Hoshimoto M; Higashino T; Itabashi T; Takada K; Sakaguchi M; Tominaga K; Kusano M; Higuchi K
    J Gastroenterol Hepatol; 2018 Mar; 33(3):623-630. PubMed ID: 28865098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: sitafloxacin for H. pylori infection in Japan: considerations on resistance rates, generalisability and its place in the therapeutic algorithm - author's reply.
    Sugimoto M
    Aliment Pharmacol Ther; 2015 Oct; 42(7):943-4. PubMed ID: 26331564
    [No Abstract]   [Full Text] [Related]  

  • 11. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Helicobacter pylori infection in patients with functional dyspepsia, eradication rates in the Donetsk region].
    Dorofeev AÉ; Rudenko NN; Agibalov AN; Kugler TE; Sibilev AV; Tomash OV
    Lik Sprava; 2014 Nov; (11):119-22. PubMed ID: 25528848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
    Nagahara A; Asaoka D; Hojo M; Oguro M; Shimada Y; Ishikawa D; Osada T; Kawabe M; Yoshizawa T; Otaka M; Watanabe S
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S122-8. PubMed ID: 20586853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimens.
    Liu MK; Wu IC; Lu CY; Kuo CH; Yu FJ; Liu CJ; Hsu PI; Hsu WH; Su YC; Chen A; Wu DC; Kuo FC; Chen JJ
    Kaohsiung J Med Sci; 2013 Jul; 29(7):379-84. PubMed ID: 23768702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common Gastrointestinal Symptoms: dyspepsia and Helicobacter pylori.
    Fashner J; Gitu AC
    FP Essent; 2013 Oct; 413():24-8. PubMed ID: 24124704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.
    Lee H; Hong SN; Min BH; Lee JH; Rhee PL; Lee YC; Kim JJ
    Dig Liver Dis; 2015 Feb; 47(2):114-8. PubMed ID: 25467826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori treatment in children: defining a dose for rabeprazole as a part of a triple therapy regimen.
    Kimko H; Thyssen A; Mould DR; Mannaert E; Treem WR
    J Clin Pharmacol; 2015 May; 55(5):592-600. PubMed ID: 25639255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Non-Inferiority Study: Modified Dual Therapy Consisting Higher Doses of Rabeprazole Is as Successful as Standard Quadruple Therapy in Eradication of Helicobacter pylori.
    Sapmaz F; Kalkan IH; Atasoy P; Basyigit S; Guliter S
    Am J Ther; 2017; 24(4):e393-e398. PubMed ID: 26495881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
    Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T
    Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differences between European guideline and planned S3 guideline of DGVS. Need for Helicobacter pylori eradication to be decided on an individual basis].
    MMW Fortschr Med; 2008 Jun; 150(23):48-9. PubMed ID: 18578071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.